Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Jia Hau Liu"'
Autor:
Yi-Che Huang, Fei-Yuan Hsiao, Shang-Ting Guan, Ming Yao, Chia-Jen Liu, Tzu-Ting Chen, Tung-Liang Lin, Yi-Chang Liu, Tsai-Yun Chen, Ying-Chung Hong, Ming-Chun Ma, Tran-Der Tan, Chuan-Cheng Wang, Yi-Ying Wu, Po-Wei Liao, Yi-Feng Wu, Yi-Yang Chen, Yuan-Bin Yu, Yao-Yu Hsieh, Ming-Yang Lee, Jia-Hau Liu, Shu-Wen Lin, Bor-Sheng Ko
Publikováno v:
Journal of Microbiology, Immunology and Infection, Vol 57, Iss 3, Pp 365-374 (2024)
Background: Cytomegalovirus (CMV) can cause infection and critical diseases in hematopoietic stem cell transplantation (HSCT) recipients. This study aimed to explore the cumulative incidence and risk factors for CMV infection and disease among HSCT r
Externí odkaz:
https://doaj.org/article/cadc1164e17747ccabdec6233ae272f6
Publikováno v:
HemaSphere, Vol 7, p e9313153 (2023)
Externí odkaz:
https://doaj.org/article/1366f378cc7e4973948a99630713d908
Autor:
Yu‐Hung Wang, Feng‐Ming Tien, Cheng‐Hong Tsai, Huai‐Hsuan Huang, Jia‐Hau Liu, Xiu‐Wen Liao, Jih‐Luh Tang, Ming Yao, Bor‐Sheng Ko
Publikováno v:
Cancer Reports, Vol 5, Iss 3, Pp n/a-n/a (2022)
Abstract Background Allogeneic stem cell transplantation (allo‐HSCT) is the ultimate cure for acute lymphoblastic leukemia (ALL). Aim This study was performed to compare the outcomes of ALL patients receiving busulfan (Bu) with cyclophosphamide (Cy
Externí odkaz:
https://doaj.org/article/7c73caafb79c4ebfa2b45d8ac3d92733
Publikováno v:
Journal of the Formosan Medical Association, Vol 118, Iss 10, Pp 1466-1470 (2019)
Hodgkin lymphoma (HL) is a highly curable hematologic malignancy. Relapsed/refractory (R/R) HL is an important clinical challenge, despite advances in treatment. Brentuximab vedotin (BV) is highly effective in R/R HL in the western world. However, th
Externí odkaz:
https://doaj.org/article/e84b191d85e74cf8a035cd62adbfcd5f
Autor:
Bor-Sheng Ko, Yu-Fen Wang, Jeng-Lin Li, Chi-Cheng Li, Pei-Fang Weng, Szu-Chun Hsu, Hsin-An Hou, Huai-Hsuan Huang, Ming Yao, Chien-Ting Lin, Jia-Hau Liu, Cheng-Hong Tsai, Tai-Chung Huang, Shang-Ju Wu, Shang-Yi Huang, Wen-Chien Chou, Hwei-Fang Tien, Chi-Chun Lee, Jih-Luh Tang
Publikováno v:
EBioMedicine, Vol 37, Iss , Pp 91-100 (2018)
Background: Multicolor flow cytometry (MFC) analysis is widely used to identify minimal residual disease (MRD) after treatment for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). However, current manual interpretation suffers from dr
Externí odkaz:
https://doaj.org/article/1fb5a7f439a34f4892ac106e7d02248b
Adding reservoirs as extensions to a multi-cavity runner-system to regulate cavity fill-rate within small, high-precision optical parts during filling and fill-to-pack switch-over (F/P) was studied with the aid of simulations. This work aimed for a c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a9ec1613b82f2cadb5b77d5ba4754ab
Autor:
Feng-Ming Tien, Hsin-An Hou, Jih-Luh Tang, Yuan-Yeh Kuo, Chien-Yuan Chen, Cheng-Hong Tsai, Ming Yao, Chien-Ting Lin, Chi-Cheng Li, Shang-Yi Huang, Bor-Sheng Ko, Szu-Chun Hsu, Shang-Ju Wu, Jia-Hau Liu, Sheng Chieh Chou, Woei Tsay, Mei-Hsuan Tseng, Ming-Chih Liu, Chia-Wen Liu, Liang-In Lin, Wen-Chien Chou, Hwei-Fang Tien
Publikováno v:
Haematologica, Vol 103, Iss 11 (2018)
Externí odkaz:
https://doaj.org/article/b5617c9e41f041c086ae44b00c80a901
Autor:
Wen-Chien Chou, Sheng-Chuan Huang, Ming-Chih Liu, Xiu-Wen Liao, Yuan-Yeh Kuo, Mei-Hsuan Tseng, Jia-Hau Liu, Shang-Ju Wu, Hwei-Fang Tien, Chien-Yuan Chen, Hsin-An Hou, Liang-In Lin, Yen-Ling Peng, Szu-Chun Hsu, Bor-Sheng Ko, Ming Yao, Yi-Kuang Chuang, Feng-Ming Tien, Jih-Luh Tang, Chiawen Liu, Mei-Fang Hou, Yu-Sin Wu, Cheng-Hong Tsai
Publikováno v:
Bone Marrow Transplantation. 57:95-105
The mutant burden of FLT3-ITD modulates its prognostic impact on patients with acute myeloid leukemia (AML). However, for patients with low allelic ratio (AR) FLT3-ITD (FLT3-ITDlow, AR
Autor:
Albert M. Wu, Jia Hau Liu
Publikováno v:
Glycoconjugate Journal. 36:175-183
Lectins, in combination with our established enzyme-linked lectin sorbent assay (ELLSA) and inhibition study, have been used as powerful tools in many glycoconjugate recognition studies. In this short review, we highlight the following: (i) The recog
Autor:
Wen-Chien Chou, Chien-Hung Chen, Jih-Luh Tang, Yao-Chang Chen, Ming Yao, Chien-Ting Lin, Cheng-Hong Tsai, Hsin-An Hou, Jia-Hau Liu, Hwei-Fang Tien, Shang-Ju Wu, Bor-Sheng Ko, Shang-Yi Huang, Chi-Cheng Li, Xiu-Wen Liao
Publikováno v:
British Journal of Haematology. 186:72-85
Reactivation of hepatitis B virus (HBV) by reverse seroconversion (HBV-RS) after allogeneic haematopoietic stem cell transplantation (allo-HSCT) can occur in patients with resolved HBV infection (rHBV, defined as negative HBV surface antigen [HBsAg]